29 results on '"Dehdashti, Farrokh"'
Search Results
2. Pilot Study: PARP1 Imaging in Advanced Prostate Cancer
3. Correction to: Co‑clinical FDG‑PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer
4. Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer
5. Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy
6. Spatial relationship of 2-deoxy-2-[18F]-fluoro-D-glucose positron emission tomography and magnetic resonance diffusion imaging metrics in cervical cancer
7. Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer
8. Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer
9. Correlation of Ki-67 Proliferative Antigen Expression and Tumor Response to Induction Chemotherapy Containing Cell Cycle-Specific Agents in Head and Neck Squamous Cell Carcinoma
10. [89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer
11. Indeterminate Findings on Oncologic PET/CT: What Difference Does PET/MRI Make?
12. Phase 1 Evaluation of [64Cu]DOTA-Patritumab to Assess Dosimetry, Apparent Receptor Occupancy, and Safety in Subjects with Advanced Solid Tumors
13. PET/MRI for the body imager: abdominal and pelvic oncologic applications
14. Response to the Letter to the Editor Regarding the Manuscript Entitled “Positron Emission Tomography with [18F]-3′-Deoxy-3′Fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: A Pilot Study”
15. Temporal analysis of intratumoral metabolic heterogeneity characterized by textural features in cervical cancer
16. Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma
17. Positron Emission Tomography with [18F]-3′-Deoxy-3′fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: a Pilot Study
18. Exclusion of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Aspiration Cytology After Negative 18F-Fluorodeoxyglucose Positron Emission Tomography: Interim Analysis
19. Unique site- and time-specific patterns of recurrence following resection of colorectal carcinoma hepatic metastases in patients staged by FDG-PET
20. PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer
21. Combined [18F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) for Detection of Recurrent, 131I-Negative Thyroid Cancer
22. Comparison of Molecular Markers of Hypoxia and Imaging with 60Cu-ATSM in Cancer of the Uterine Cervix
23. Oncologic PET/CT: current status and controversies
24. FDG uptake in colonic villous adenomas
25. Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET
26. Positron tomographic assessment of androgen receptors in prostatic carcinoma
27. In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM
28. Positron emission tomographic assessment of ?metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy
29. Detection of recurrent and metastatic colorectal cancer: Comparison of positron emission tomography and computed tomography
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.